← Back to Search

Diabetes Dashboard integrated with Disease Manager App for Diabetes

N/A
Waitlist Available
Led By Kawamoto Kensaku, MD, PhD, MHS
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 12 months for the intervention period and 12 months for the baseline period
Awards & highlights

Study Summary

This trial is testing whether or not a diabetes dashboard, integrated with a disease manager app, is effective in helping manage diabetes.

Eligible Conditions
  • Diabetes
  • Type 2 Diabetes

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 12 months for the intervention period and 12 months for the baseline period
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 12 months for the intervention period and 12 months for the baseline period for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in hemoglobin A1c (HbA1c) levels
Secondary outcome measures
Change in body mass index (BMI) levels
Other outcome measures
Rate of use of the Disease Manager's diabetes module

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diabetes Dashboard integrated with Disease Manager AppExperimental Treatment1 Intervention
When patients are seen in clinics in this arm, the clinical providers will have access to the intervention (EHR-integrated Diabetes Dashboard that is integrated with the diabetes module of the Disease Manager App).

Find a Location

Who is running the clinical trial?

Hitachi, Ltd.UNKNOWN
1 Previous Clinical Trials
13,155 Total Patients Enrolled
University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,752,774 Total Patients Enrolled
4 Trials studying Diabetes
1,025 Patients Enrolled for Diabetes
Kawamoto Kensaku, MD, PhD, MHSPrincipal InvestigatorUniversity of Utah

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
Utah
How old are they?
18 - 65
What site did they apply to?
University of Utah Health
What portion of applicants met pre-screening criteria?
Met criteria
Recent research and studies
Methods of Information in MedicineJournal
Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus
Tarumi, Shinji, Wataru Takeuchi, George Chalkidis, Salvador Rodriguez-Loya, Junichi Kuwata, Michael Flynn, Kyle M. Turner, et al.. 2021. “Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus”. Methods of Information in Medicine. Georg Thieme Verlag KG. doi:10.1055/s-0041-1728757.
clinicaltrials.govStudy
Design, Implementation and Evaluation of Scalable Decision Support for Diabetes Care
Kensaku Kawamoto, MD, PhD, MHS 2021. "Design, Implementation and Evaluation of Scalable Decision Support for Diabetes Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04928248.
~7232 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top